Evidence map›Paper›PMID 11488991›Full record

ReviewInternational journal of experimental pathology2001

The functions of cytokines and their uses in toxicology.

J R Foster

Open access · greenAbstract readReview
In one paragraph

Review in International journal of experimental pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 73 citations in OpenAlex.

  1. Dietary Intake ofNutrients · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Evolution of γ chain cytokines: Mechanisms, methods and applications.Computational and structural biotechnology journal · 2022
    Review
  12. Oman medical journal · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Human corneal cell culture models for drug toxicity studies.Drug delivery and translational research · 2016
    Review
  17. Article
  18. Article
  19. Optimal method to stimulate cytokine production and its use in immunotoxicity assessment.International journal of environmental research and public health · 2013
    Article
  20. Guiding the vaginal microbicide trials with biomarkers of inflammation.Journal of acquired immune deficiency syndromes (1999) · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

J R FosterSafety Assessment, AstraZeneca plc, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. John-Foster@astrazeneca.com
AstraZeneca (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytokines are critical controllers of cell, and hence tissue, growth, migration, development and differentiation. The family includes the inflammatory cytokines such as the interleukins and interferons, growth factors such as epidermal and hepatocyte growth factor and chemokines such as the macrophage inflammatory proteins, MIP-1alpha and MIP-1beta. They do not include the peptide and steroid hormones of the endocrine system. Cytokines have important roles in chemically induced tissue damage repair, in cancer development and progression, in the control of cell replication and apoptosis, and in the modulation of immune reactions such as sensitization. They have the potential for being sensitive markers of chemically induced perturbations in function but from a toxicological point of view, the detection of cytokine changes in the whole animal is limited by the fact that they are locally released, with plasma measures being generally unreliable or irrelevant, and they have short half lives which require precise timing to detect. Even where methodology is adequate the interpretation of the downstream effects of high, local concentrations of a particular cytokine is problematic because of their interdependence and the pleiotropism of their action. A range of techniques exist for their measurement including those dependent upon antibodies specific for the respective cytokines, but with the introduction of genomic and proteomic technology, a more complete study of cytokine changes occurring under the influence of chemical toxicity should be possible. Their further study, as markers of chemical toxicity, will undoubtedly lead to a greater understanding of how synthetic molecules perturb normal cell biology and if, and how, this can be avoided by more intuitive molecular design in the future.

Indexed as

AnimalsApoptosisBiological AssayBiomarkersCell DifferentiationCell DivisionCytokinesDrug HypersensitivityElectrophoresisEnzyme-Linked Immunosorbent AssayFlow CytometryHumansImmunohistochemistryIn Situ HybridizationMacrophagesModels, BiologicalBiomarkersCytokines

Identifiers

PMID11488991
PMCPMC2517710
OpenAlexW2055186844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.